iPS Cells for Modelling and Treatment of Human Diseases
The field of reprogramming somatic cells into induced pluripotent stem cells (iPSC) has moved very quickly, from bench to bedside in just eight years since its first discovery. The best example of this is the RIKEN clinical trial this year in Japan, which will use iPSC derived retinal pigmented epit...
Shranjeno v:
| Format: | Online |
|---|---|
| Jezik: | angleščina |
| Izdano: |
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Teme: | |
| Online dostop: | 19008 |
| Oznake: |
Brez oznak, prvi označite!
|